As a pre-mRNA splicing inhibitor, HNRNPA1 regulates CD44 isoforms, and low levels of HNRNPA1 can significantly inhibit cell invasion and induce cell death in breast cancer [32]. Here, CD44 is linked to breast carcinoma.